Skip to main content
. 2018 Jun 1;57(9):1602–1610. doi: 10.1093/rheumatology/key100

Table 1.

Demographic and other baseline characteristics

Cohort 1 Cohort 2 Cohort 3 Cohort 4 Cohort 5 Cohort 6
(n = 12) (n = 12) (n = 12) (n = 12) (n = 12) (n = 12)
Age, mean (s.d.), years 41.1 (10.6) 44.7 (16.2) 44.2 (8.2) 43.2 (9.8) 48.1 (12.8) 44.4 (13.8)
Body weight, mean (s.d.), kg 82.27 (14.14) 78.48 (16.84) 74.16 (8.62) 78.47 (11.8) 78.96 (10.94) 73.83 (6.05)
BMI, mean (s.d.), kg/m2 28.1 (4.5) 27.5 (5.3) 24.9 (2.5) 27.1 (4.2) 27.4 (3.4) 25.2 (2.6)
Gout, n (%) 5 (41.7) 6 (50.0) 6 (50.0) 7 (58.3) 6 (50.0) 7 (58.3)
Asymptomatic hyperuricaemia, n (%) 7 (58.3) 6 (50.0) 6 (50.0) 5 (41.7) 6 (50.0) 5 (41.7)
sUA, screening, mean (s.d.), mg/dl 9.17 (1.09) 8.56 (0.60) 8.53 (0.74) 8.99 (0.95) 8.57 (0.61) 8.86 (0.85)
eGFR, mean (s.d.), ml/min 119 (19.7) 120 (32.2) 113 (19.7) 106 (23.8) 105 (24.0) 107 (22.2)

eGFR= [(140 − age) × ideal body weight (kg)]/[72 × serum creatinine (mg/dl)]. eGFR: estimated glomerular filtration rate based on serum creatinine, age and ideal body weight; sUA: serum urate.